Search results for: Pricing and Reimbursement
Filter search results
OHE Lunchtime Seminar: The People’s Prescription – Re-imagining Health Innovation to Deliver Public Value
7 September 2018
…financialisation and the obligation to maximise shareholder value through profit, the pharmaceutical sector is increasingly under pressure to deliver short-term financial returns through raising drug prices and executing share buybacks…
OHE Lunchtime Seminars: Steven Pearson and Janel Hanmer
4 October 2018
…will be hosting two lunchtime seminars this month. OHE Lunchtime Seminar with Steven Pearson on ‘Early experience with HTA of gene therapies in the US: pricing and paying for cures’….
OHE Lunchtime Seminar: How Do We Measure the ‘Value’ in Value-based Care?
19 August 2019
…outcomes. The weakness is that ‘value’ is not clearly defined and outcome measures focus on issues that are primarily of interest to clinicians and not patients. An alternative outcomes model…
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
14 April 2020
…systems and from the availability of treatments. These are over and above any value to the health system from decision makers having greater certainty about the benefits and costs of…
OHE Innovation Policy Prize
18 May 2022
…the birth of health economics and has contributed to the development of novel theory and methodology, shaped the major policy and academic debates, and played a role in ultimately improving…
Science, Industry in the State
7 January 1965
…those with an interest in science-based industry, its economics, and its relationship with government; by civil servants, administrators and members of committees; and by all students of this important subject….
Innovation Balance of Payments: the Experience of the Pharmaceutical Industry
1 July 1967
…pattern of international pharmaceutical trade. The next two papers discuss the commercial considerations, such as profitability, pricing, use of brand names and sales promotion, which also affect an industry’s success…
Economics and Innovation the Pharmaceutical Industry
1 July 1969
…Health Economics was concerned to have the pricing policies and other behaviour of the pharmaceutical industry critically explored. Readers who are properly sceptical about the motives and inhibitions of a…
The Publicly Funded Vaccines Market in the UK
1 October 2010
…the UK. It includes observations as to whether and how the economic assessment process differs for vaccines compared to curative pharmaceutical products and the implications of the current pricing approach….